Angela Pietrofeso
Vice President, Clinical Operations
Angela Pietrofeso has over 20 years of experience in clinical research and global drug development. She most recently served as Vice President, Clinical Development Operations at Oncternal Therapeutics where she successfully built and led a high-performing clinical and safety operations team across multiple oncology programs. Through her career, Angela has led programs from early-phase clinical development through regulatory submission, with therapeutic expertise spanning oncology, ulcerative colitis, cardiovascular devices, acute pain, and infectious diseases. Her contributions have led to the approval of Sutent® at Pfizer and other approvals outside of oncology drug development.
Before joining Oncternal, Angela held positions of increasing responsibility at Gossamer Bio, W.L Gore & Associates, Lithera, Cadence Pharmaceuticals, Metabasis, Valeant, and Pfizer. Prior to joining industry, she worked as a Research Nurse Manager at the Royal Free Hospital (London UK) and as a Registered Nurse in South Africa and UK. Angela holds a Bachelor of Social Science (Nursing) from University of Natal (Durban South Africa).